Cargando…

Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome

INTRODUCTION: Monoclonal antibodies (mAb) targeting plasma cells are malignant gammopathy designed and approved therapies. In recent years, these antibodies have also been increasingly introduced for non-malignant conditions such as autoimmune-mediated diseases. The Anti-Phospholipid Syndrome (APS)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pleguezuelo, Daniel E., Díaz-Simón, Raquel, Cabrera-Marante, Oscar, Lalueza, Antonio, Paz-Artal, Estela, Lumbreras, Carlos, Serrano Hernández, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072150/ https://www.ncbi.nlm.nih.gov/pubmed/33912194 http://dx.doi.org/10.3389/fimmu.2021.667515

Ejemplares similares

Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution
por: Garcinuño, Sara, et al.
Publicado: (2022)

Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor
por: Gil-Etayo, Francisco Javier, et al.
Publicado: (2021)

T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression
por: Gil-Etayo, Francisco Javier, et al.
Publicado: (2021)

Immune Complexes of Beta-2-Glycoprotein I and IgA Antiphospholipid Antibodies Identify Patients With Elevated Risk of Thrombosis and Early Mortality After Heart Transplantation
por: Serrano, Manuel, et al.
Publicado: (2019)

An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution
por: Gil-Etayo, Francisco Javier, et al.
Publicado: (2022)

The Weight of IgA Anti-β2glycoprotein I in the Antiphospholipid Syndrome Pathogenesis: Closing the Gap of Seronegative Antiphospholipid Syndrome
por: Cabrera-Marante, Oscar, et al.
Publicado: (2020)

Incidence of thromboembolic events in asymptomatic carriers of IgA anti ß2 glycoprotein-I antibodies
por: Tortosa, Carlos, et al.
Publicado: (2017)

Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management
por: López-Nevado, Marta, et al.
Publicado: (2021)

Immune Response Against SARS-CoV-2 Infection and Vaccination in a CD8α-Deficient Patient
por: Arroyo-Sánchez, Daniel, et al.
Publicado: (2023)

Perforin gene variant A91V in young patients with severe COVID-19
por: Cabrera-Marante, Oscar, et al.
Publicado: (2020)

Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency
por: Arroyo-Sánchez, Daniel, et al.
Publicado: (2021)

Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic Stroke
por: Naranjo, Laura, et al.
Publicado: (2021)

Daratumumab for the Treatment of Multiple Myeloma
por: Plesner, Torben, et al.
Publicado: (2018)

Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2022)

Alterations in Circulating Monocytes Predict COVID-19 Severity and Include Chromatin Modifications Still Detectable Six Months after Recovery
por: Utrero-Rico, Alberto, et al.
Publicado: (2021)

Defending against SARS-CoV-2: The T cell perspective
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2023)

Tolerogenic Role of Myeloid Suppressor Cells in Organ Transplantation
por: Ochando, Jordi, et al.
Publicado: (2019)

A Short Corticosteroid Course Reduces Symptoms and Immunological Alterations Underlying Long-COVID
por: Utrero-Rico, Alberto, et al.
Publicado: (2021)

Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE
por: Humbel, Morgane, et al.
Publicado: (2021)

Reversal of Immunity After Clearance of Chronic HCV Infection—All Reset?
por: Wedemeyer, Heiner, et al.
Publicado: (2020)

The Immunomodulatory Effect and Clinical Efficacy of Daratumumab in a Patient With Cold Agglutinin Disease
por: Zaninoni, Anna, et al.
Publicado: (2021)

Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia
por: Pereda, Maria A., et al.
Publicado: (2022)

Reset Control Systems
por: Baños, Alfonso, et al.
Publicado: (2012)

Acquired and Innate Immunity Impairment and Severe Disseminated Mycobacterium genavense Infection in a Patient With a NF-κB1 Deficiency
por: Gonzalez-Granado, Luis Ignacio, et al.
Publicado: (2019)

Commentary: Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia
por: Jacobs, Jeremy W., et al.
Publicado: (2023)

CD38-specific nanobodies allow in vivo imaging of multiple myeloma under daratumumab therapy
por: Pape, Luca Julius, et al.
Publicado: (2022)

Resetting the T Cell Compartment in Autoimmune Diseases With Autologous Hematopoietic Stem Cell Transplantation: An Update
por: Lutter, Lisanne, et al.
Publicado: (2018)

Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2021)

Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss
por: Pleguezuelo, Daniel E., et al.
Publicado: (2021)

Brief Research Report: Virus-Specific Humoral Immunity at Admission Predicts the Development of Respiratory Failure in Unvaccinated SARS-CoV-2 Patients
por: Tajuelo, Ana, et al.
Publicado: (2022)

Corrigendum: Brief Research Report: Virus-Specific Humoral Immunity at Admission Predicts the Development of Respiratory Failure in Unvaccinated SARS-CoV-2 Patients
por: Tajuelo, Ana, et al.
Publicado: (2022)

Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome
por: Borghi, Maria Orietta, et al.
Publicado: (2020)

Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab
por: Baumann, Niklas, et al.
Publicado: (2022)

Cellular and Molecular Mechanisms of Anti-Phospholipid Syndrome
por: Radic, Marko, et al.
Publicado: (2018)

Acquired Senescent T-Cell Phenotype Correlates with Clinical Severity in GATA Binding Protein 2-Deficient Patients
por: Ruiz-García, Raquel, et al.
Publicado: (2017)

SARS-CoV-2-specific T-cell responses after COVID-19 recovery in patients with rheumatic diseases on immunosuppressive therapy
por: Lledó, Ana, et al.
Publicado: (2021)

Efficacy and Safety of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Compared to Daratumumab, Bortezomib, and Dexamethasone (DVd) in Daratumumab–Naïve Relapsed Multiple Myeloma
por: Afrough, Aimaz, et al.
Publicado: (2023)

A Semi-Deterministic Random Walk with Resetting
por: Villarroel, Javier, et al.
Publicado: (2021)

Daratumumab Prevents Experimental Xenogeneic Graft-Versus-Host Disease by Skewing Proportions of T Cell Functional Subsets and Inhibiting T Cell Activation and Migration
por: Gao, Yang, et al.
Publicado: (2021)

Efficacy and Safety of Durvalumab Combined with Daratumumab in Daratumumab-Refractory Multiple Myeloma Patients
por: Frerichs, Kristine A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lfdr8opkk7tu77olu35r0u5gov